Sign in: Staff/Students
The study found antihydrogen and hydrogen had the same gravity
Scientists at the University of Liverpool have measured for the first time the effect of gravity on antihydrogen – the antimatter counterpart of hydrogen – marking an important step in understanding how antimatter behaves.
Whilst scientific evidence led scientists to assume that antihydrogen had exactly the same properties as hydrogen, it had not been proven.
Researchers from the University of Liverpool were part of CERN’s international ALPHA experiment which performed measurements on antihydrogen. They trapped and then released antihydrogen atoms in order to measure its freefall gravity which enabled them to determine the ratio of antihydrogen’s gravitational mass to its inertial mass.
If it was exactly one to one then antimatter and matter responded to gravity in the same way and therefore had the same properties.
However, due to the uncertainty in making this measurement, the team were able to put an upper limit on this ratio of lower than one to 75, in the absence of systematic errors. They also obtained a similar limit for the behaviour under antigravity but this still meant they responded in the same way.
Professor Paul Nolan, from the Department of Physics who led the Liverpool team, said: “We studied antihydrogen and made detailed comparisons with ordinary hydrogen and found that they had the same gravity.
“Although the data does not allow a more accurate limit to be determined yet, future developments to the apparatus and methodology will allow the researchers to improve these measurements and test more accurately for possible deviations.”
The University’s Semiconductor Centre group was responsible for building, maintaining and operating the silicon vertex detector which detects the presence of the antimatter particle of antihydrogen and allows gravity measurements to be made on antimatter particles.
The work is published in Nature Communications and supported by the Engineering and Physical Sciences Research Council (EPSRC).
You must be logged in to post a comment.
All recent news
Extending Duo two-factor authentication (2FA) to Canvas
World AIDS Day: Are long-acting HIV therapies the future?
Get involved: Activities and events happening this week
New UK coronavirus measures introduced
Obituary: Dr Stephan Pfaffenzeller
Leading experts in the fields of pharmacology and advanced materials, Prof Andrew Owen and Prof Steve Rannard from @CELTLiverpool discuss their pioneering work into long-acting therapeutics for the treatment of HIV.
Full story ➡️ https://bit.ly/3G5Nc3s
Persistent poverty and/or persistent poor parental mental health affects over four in ten children in UK today, @LivUni-led analysis finds ➡️ https://bit.ly/3xButtM
£1.6m programme led by @MPUoL seeks to understand the very rare, but very serious, condition of blood clotting with low platelets in the general population, in #COVID19 infection & potentially following vaccination ➡️ https://bit.ly/3o5GtR1